Boehringer Ingelheim

We have been transforming lives in healthcare since 1885. Our 53,500 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.

We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives. 

230714_BI_Bildwelt_Celebration_Of_Successes_35mm_00864

Latest Articles

Boehringer Ingelheim flags

Board of Managing Directors

As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of six members. Read more about their respective responsibilities.

Missy Pappion_0.jpg
Corporate Profile

Finding the long-missed meaning

Cancer survivor Missy Pappion is happy at Boehringer Ingelheim after climbing the corporate ladder.
Read more
Innovation is not an abstract concept", says Hubertus von Baumbach. "It means new diagnostics, treatments and vaccines that can transform the lives of people.
Corporate Profile

Europe needs a vibrant research eco-system

At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
Read more
Vet volunteers
Corporate Profile

Big hearts united to help

Veterinaries help our four-legged friends in the Poland-Ukrainian border.
Read more

Links

Downloads